EarningsQ2 2024 Earnings Report

Biora Therapeutics (4ZU) Q2 2024 Earnings Report

0 Followers

DE:4ZU Q2 2024 EPS Results

Actual EPS€1.61

Consensus EPS-€4.02

Beat/MissBeat by +€5.62

One Year Ago EPS-€13.12

Actual Revenue€283.78K

Expected Revenue€0.00

Beat/MissBeat by +€283.78K

YoY Revenue Growth+15800.00%

QuarterQ2 2024

Date08/12/2024

TimeAfter Close

Conference CallMonday, August 12, 2024

DE:4ZU Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2025	2025 (Q3)	- / -	-5.426	―
Aug 18, 2025	2025 (Q2)	- / -	0.161	―
May 07, 2025	2025 (Q1)	- / -	―	―
Mar 26, 2025	2024 (Q4)	-3.12 / -	-5.578	―
Nov 14, 2024	2024 (Q3)	-3.44 / -5.43	-43.639	87.57% (+38.21)
Aug 12, 2024	2024 (Q2)	-4.02 / 1.61	-13.118	112.24% (+14.72)
May 15, 2024	2024 (Q1)	-4.02 / -1.25	-14.189	91.19% (+12.94)
Mar 26, 2024	2023 (Q4)	-5.31 / -5.58	-14.368	61.18% (+8.79)
Nov 13, 2023	2023 (Q3)	-8.25 / -43.64	-6.693	-552.00% (-36.95)
Aug 14, 2023	2023 (Q2)	-14.28 / -13.12	-6.693	-96.00% (-6.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed